Endoscopic dilatation of esophageal strictures in children and adolescents

2006 ◽  
Vol 82 (2) ◽  
pp. 127-131 ◽  
Author(s):  
Paulo Fernando Souto Bittencourt ◽  
Simone Diniz Carvalho ◽  
Alexandre Rodrigues Ferreira ◽  
Suzana Fonseca Oliveira Melo ◽  
Denise Oliveira Andrade ◽  
...  
2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 76-76
Author(s):  
Keat How Teoh ◽  
Kelvin Voon ◽  
Shyang Yee Lim ◽  
Premnath Nagalingam

Abstract Background Caustic injury remains the commonest cause of benign esophageal strictures in Asia. Others include gastroesophageal reflux, iatrogenic, radiation, autoimmune or idiopathic causes. Treatment goals are relief of dysphagia and prevention of recurrence. This study aims to evaluate the experience with benign esophageal stricture in Penang Hospital, a tertiary hospital in Northern region of Malaysia. Methods A retrospective review of 12 patients with benign esophageal strictures between year 2012 - 2017. Results The mean age was 53.5 and two thirds were female. Half of these patients were of Chinese ethnicity while the other half were Indian. The commonest cause was caustic ingestion (41.7%), followed by reflux stricture (25%) and anastomotic stricture (25%). There was one case of dystrophic epidermolysis bullosa. More than half of the patients had complex and multiple strictures. 41.7% of patients had proximal strictures that were located within 20cm from the incisors. Endoscopic dilatation was the first line treatment with either Savary Gilliard or balloon dilators. A total of 97 dilatation sessions were done with a mean dilatation frequency of 2.3 ± 1.5 times for anastomotic strictures, 8 ± 8.2 times for reflux strictures and 8.0 ± 6.6 times for corrosive strictures. The mean dilatation interval was 2.5 ± 1.2 weeks. 58.3% of patients had successful endoscopic treatment. The success rate was higher in non-corrosive stricture (83% vs 40%). There was one dilatation related complication in which the patient had pneumomediastinum without overt mediastinitis. This however, resolved with conservative management. 41.7% of patients had refractory strictures that failed endoscopic dilatation. Surgery including esophagectomy (40%), revision of anastomosis (20%) and gastrostomy (40%) were done for this group of patients. Proximal strictures, complex strictures and multiple strictures were associated with failed endoscopic dilatation (P < 0.05). Conclusion Endoscopic dilatation is the first line treatment for benign esophageal strictures. Surgery is reserved for refractory strictures with failed endoscopic treatment. Predictor scoring systems for refractory stricture and individualized approaches are the key to success. Disclosure All authors have declared no conflicts of interest.


1996 ◽  
Vol 43 (5) ◽  
pp. 474-477 ◽  
Author(s):  
Sohan L. Broor ◽  
Desepak Lahoti ◽  
Partha P. Bose ◽  
Ganesh N. Ramesh ◽  
Gottumukkala S. Raju ◽  
...  

2021 ◽  
Vol 14 ◽  
pp. 175628482098529
Author(s):  
Einas Abou Ali ◽  
Arthur Belle ◽  
Rachel Hallit ◽  
Benoit Terris ◽  
Frédéric Beuvon ◽  
...  

Background: Endoscopic resection of extensive esophageal neoplastic lesions is associated with a high rate of esophageal stricture. Most studies have focused on the risk factors for post-endoscopic esophageal stricture, but data on the therapeutic management of these strictures are scarce. Our aim is to describe the management of esophageal strictures following endoscopic resection for early esophageal neoplasia. Methods: We included all patients with an endoscopic resection for early esophageal neoplasia followed by endoscopic dilatation at a tertiary referral center. We recorded the demographic, endoscopic, and histological characteristics, and the outcomes of the treatment of the strictures. Results: Between January 2010 and December 2019, we performed 166 endoscopic mucosal resections and 261 endoscopic submucosal dissections for early esophageal neoplasia, and 34 (8.0%) patients developed an esophageal stricture requiring endoscopic treatment. The indication for endoscopic resection was Barrett’s neoplasia in 15/34 (44.1%) cases and squamous cell neoplasia (SCN) in 19/34 (55.9%) cases. The median [(interquartile range) (IQR)] number of endoscopic dilatations was 2.5 (2.0–4.0). Nine of 34 (26.5%) patients required only one dilatation, and 22/34 (65%) had complete dysphagia relief following three endoscopic treatment sessions. The median number of dilatations was significantly higher for SCN [3.0 (2–7); range 1–17; p = 0.02], and in the case of circumferential resection [4.0 (3.0–7.0); p = 0.03]. Endoscopic dilatation allowed a sustained dysphagia relief in 33/34 (97.0%) patients after a mean follow-up of 25.3 ± 22 months. Conclusion: Refractory post-endoscopic esophageal stricture is a rare event. After a median of 2.5 endoscopic dilatations, 97.0% of patients were permanently relieved of dysphagia. Circumferential endoscopic esophageal resections should be considered when indicated.


1990 ◽  
Vol 10 (2) ◽  
pp. 176-181 ◽  
Author(s):  
Abdel Rahman El Shiekh Mohamed ◽  
Mohamed Ali Al-Karawi ◽  
Mohamed Ismail Yassawy

QJM ◽  
2020 ◽  
Vol 113 (Supplement_1) ◽  
Author(s):  
H S Abdelhamid ◽  
K M Elasmar ◽  
A A Zaki ◽  
W A Ghanem ◽  
M M Elbehery

Abstract Background Corrosive ingestion is a devastating event that induces significant burdens on modern health systems worldwide. The management of resulting esophageal strictures is challenging where endoscopic dilatation is the first line of management with varying rate of success. Aim of the Work We aimed at this work to study the feasibility and safety of intralesional Mitomycin C injection in patients with caustic localized esophageal stricture. Patients and Methods This study has been conducted at Pediatric Surgery Department, Pediatric Hospital, Ain Shams University Hospitals on eight pediatric patients with caustic esophageal stricture with variable degrees of dysphagia. We evaluated the clinical improvement of the dysphagia, as well as the intra and postoperative complications of Mitomycin C injection. Results Eight patients with short caustic esophageal stricture were managed with intralesional Mitomycin C injection adjuvant to endoscopic dilatation. Seven patients were completely cured from dysphagia with at least 6 months dysphagia free period. No intraoperative complications were documented while there were two cases who reported GIT side effect postoperative in the form of colics and non-bilious vomiting that resolved by medical treatment. Conclusion Intralesional Mitomycin C injection could be a good adjuvant therapy with endoscopic dilatation for caustic esophageal stricture. However, long-term observations are mandatory on a large scale of patients.


2018 ◽  
Vol 39 (8) ◽  
pp. 787-791 ◽  
Author(s):  
Ahmed Al Sarkhy ◽  
Anjum Saeed ◽  
Yassin Hamid ◽  
Mona Al Asmi ◽  
Tariq Altokhais ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document